Health Canada Approves Delgocitinib Cream (Anzupgo, LEO Pharma) for Chronic Hand Eczema
Health Canada has approved delgocitinib cream 20mg/g (Anzupgo, LEO Pharma) for the treatment of adults (aged ≥18 years) with moderate-to-severe chronic hand eczema (CHE) for whom topical corticosteroids are inadequate or are not advisable.